Williams Laura A 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Williams Laura A（CIK 1869194）在 1 家公司共报告 21 笔 SEC Form 4 内部人交易（最近一笔 2026-08-25）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-25 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 3,486 | $13,445 |
| 2026-08-25 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 3,089 | $11,914 |
| 2026-08-25 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 2,430 | $9,372 |
| 2026-08-25 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 1,734 | $6,688 |
| 2026-06-22 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 买入 | 31,000 | $30,690 |
| 2026-06-22 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 81,898 | $490,569 |
| 2026-05-22 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 1,503 | $9,424 |
| 2026-05-22 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 2,157 | $13,524 |
| 2026-05-22 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 1,911 | $11,982 |
| 2026-05-22 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 1,418 | $8,891 |
| 2026-02-23 | ARDELYX, INC. (ARDX) | Chief Patient Officer and interim Chief Medical Officer | 卖出 | 7,192 | $42,217 |
| 2026-02-23 | ARDELYX, INC. (ARDX) | Chief Patient Officer and interim Chief Medical Officer | 卖出 | 984 | $5,619 |
| 2026-01-26 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 买入 | 82,695 | $0 |
| 2026-01-09 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 买入 | 50,000 | $49,500 |
| 2026-01-09 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 50,000 | $349,000 |
| 2025-11-25 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 6,426 | $35,600 |
| 2025-08-28 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 买入 | 50,000 | $49,500 |
| 2025-08-28 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 50,000 | $306,000 |
| 2025-08-28 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 30,000 | $183,600 |
| 2025-08-25 | ARDELYX, INC. (ARDX) | Chief Patient Officer | 卖出 | 6,261 | $37,128 |
| 2025-05-22 | ARDELYX, INC. (ARDX) | Chief Medical Officer | 卖出 | 6,421 | $26,198 |
来源：SEC Form 4 申报文件 · 截至 2026-08-25